The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.
Advertisement
The email address for your subscription is newsletter@newslettercollector.comManage Email Preferences or Unsubscribe
New York Post 1211 Avenue of the Americas New York, NY 10036 USA
© Copyright 2020 NYP Holdings, Inc. All rights reservedPrivacy | Terms of Use | Your Ad Choices